Delivery Order SPE2DB22D2206-SPE2DB25FHY94
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 100 mg capsules in a 60-count configuration. This competitive delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed-price pharmaceutical procurement to support federal medical supply needs. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Ofev 150 mg capsules. The contract has a ceiling value of $7,905.56 and a performance period ending on May 3, 2024. This order is part of Amerisourcebergen's prime contractor role on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $8,590.58 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has an ultimate completion date of January 24, 2025, is for the supply of OFEV 150 MG CAPSULE 60S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,220.86, is for the delivery of 60-count packages of the medication OFEV 100 MG CAPSULE. The contract has an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ofev 100 mg capsules. The contract has a ceiling value of $17,260.58 and a period of performance through May 27, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OFEV 150 mg capsules. The contract has a ceiling value of $25,771.74 and a performance period through July 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OFEV 150 mg capsules and has a ceiling value of $8,590.58. The contract is not set aside and has an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $15,287 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562290975 capsules of OFEV 100 MG CAPSULE 60S. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 25, 2023 and ending on October 17, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,905.56 contract is for the delivery of OFEV 150 MG CAPSULE 60S, a specialty pharmaceutical product, with a performance period through April 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHY94Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $8,590.58 and an ultimate completion date of August 8, 2025. The contract was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders with the DLA across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/18/25 |